Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M94,247Revenue $M9,703Net Margin (%)30.3Z-Score19.7
Enterprise Value $M92,992EPS $12.4Operating Margin %40.8F-Score9
P/E(ttm))32.6Cash Flow Per Share $7.4Pre-tax Margin (%)40.7Higher ROA y-yY
Price/Book8.310-y EBITDA Growth Rate %26.5Quick Ratio1.7Cash flow > EarningsY
Price/Sales9.85-y EBITDA Growth Rate %25.5Current Ratio2.1Lower Leverage y-yY
Price/Cash Flow20.5y-y EBITDA Growth Rate %54.7ROA % (ttm)22.6Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)30.2Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M235ROI % (ttm)19.7Gross Margin Increase y-yY

Gurus Latest Trades with BIIB

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BIIBKen Heebner 2014-12-31 Sold Out -0.75%$299.1 - $360.67
($323.29)
$ 401.7120%Sold Out0
BIIBVanguard Health Care Fund 2014-12-31 Sold Out -0.2%$299.1 - $360.67
($323.29)
$ 401.7120%Sold Out0
BIIBJoel Greenblatt 2014-12-31 Reduce-0.08%$299.1 - $360.67
($323.24)
$ 401.7120%Reduce -84.03%5,012
BIIBKen Heebner 2014-09-30 Buy 0.75%$299.29 - $346.3
($329.79)
$ 401.7118%New holding80,000
BIIBVanguard Health Care Fund 2014-09-30 Reduce-0.27%$299.29 - $346.3
($329.79)
$ 401.7118%Reduce -58.26%233,600
BIIBJoel Greenblatt 2014-09-30 Buy 0.1%$299.29 - $346.3
($329.79)
$ 401.7118%New holding31,391
BIIBKen Heebner 2014-06-30 Sold Out -0.95%$274 - $320.13
($300.74)
$ 401.7125%Sold Out0
BIIBKen Fisher 2014-06-30 Add0.05%$274 - $320.13
($300.74)
$ 401.7125%Add 386.61%88,885
BIIBVanguard Health Care Fund 2014-06-30 Reduce-0.03%$274 - $320.13
($301.05)
$ 401.7125%Reduce -6.62%559,700
BIIBGeorge Soros 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 401.7125%Sold Out0
BIIBJoel Greenblatt 2014-06-30 Sold Out -0.02%$274 - $320.13
($300.74)
$ 401.7125%Sold Out0
BIIBRon Baron 2014-06-30 Add$274 - $320.13
($300.74)
$ 401.7125%Add 41.76%8,632
BIIBMario Gabelli 2014-06-30 Add$274 - $320.13
($301.05)
$ 401.7125%Add 16.46%4,175
BIIBKen Heebner 2014-03-31 Buy 0.95%$273.518 - $351.94
($316.4)
$ 401.7121%New holding116,000
BIIBVanguard Health Care Fund 2014-03-31 Reduce-0.24%$273.518 - $351.94
($315.54)
$ 401.7121%Reduce -32.19%599,400
BIIBJoel Greenblatt 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 401.7121%New holding3,931
BIIBGeorge Soros 2014-03-31 Buy 0.02%$273.518 - $351.94
($316.4)
$ 401.7121%New holding7,500
BIIBKen Fisher 2014-03-31 Add0.01%$273.518 - $351.94
($315.54)
$ 401.7121%Add 796.27%18,266
BIIBRon Baron 2014-03-31 Buy 0.01%$273.518 - $351.94
($316.4)
$ 401.7121%New holding6,089
BIIBVanguard Health Care Fund 2013-12-31 Reduce-0.47%$223.85 - $295.88
($258.53)
$ 401.7136%Reduce -39.09%884,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BIIB is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BIIB: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCANGOS GEORGE ACEO 2015-04-01Sell1,362$423.2-5.08view
Sandrock AlfredGrp SVP, Chief Medical Officer 2015-03-27Sell430$430.12-6.61view
Cox JohnEVP Pharmaceutical Oper & Tech 2015-03-25Sell12,010$449.06-10.54view
Rowinsky Eric KDirector 2015-03-20Sell11,667$475-15.43view
Rowinsky Eric KDirector 2015-03-19Sell2,333$436.14-7.89view
Rowinsky Eric KDirector 2015-03-17Sell4,667$425.45-5.58view
DiPietro KennethEVP Human Resources 2015-03-16Sell803$415.46-3.31view
SCANGOS GEORGE ACEO 2015-03-13Sell537$412.69-2.66view
SHERWIN STEPHEN ADirector 2015-03-10Sell6,000$409.67-1.94view
PANGIA ROBERT WDirector 2015-03-10Sell3,625$413.4-2.83view

Press Releases about BIIB :

    Quarterly/Annual Reports about BIIB:

    News about BIIB:

    Articles On GuruFocus.com
    Analysts Provide Update for Biogen, PTC Therapeutics, GW Pharma, and Isis Pharma Apr 22 2015 
    Biogen And Idec To Part Ways After Inventing Alzheimer's Drug Mar 27 2015 
    Biogen’s Alzheimer’s Drug Shows Promising Test Results Mar 23 2015 
    Biogen Idec (BIIB) At All-time High Levels, KB Home (KBH) Revenue Growth Trajectory, Ctrip (CTRP) Re Mar 23 2015 
    The Best Upcoming Dividend Stocks Mar 20 2015 
    This Week’s Pharma Highlights Mar 19 2015 
    Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
    February Pick Of Biotech Stocks Feb 17 2015 
    Stanley Druckenmiller's Recent Trades Feb 13 2015 
    8 Strong Recommendations for 2015 Feb 13 2015 


    More From Other Websites
    Trusty Horses; Tools, Pizza and Shoes: Jim Cramer's Best Blogs Apr 25 2015
    Biogen’s Tough Treatment from Wall Street Apr 24 2015
    With Market Back In Uptrend, IBD 50 Growth Names Thrive Apr 24 2015
    Humana (HUM), Gilead Sciences (GILD), McKesson Corporation (MCK) Among Sivik Global’s Top... Apr 24 2015
    Stock Pops & Drops: DDD, DNKN, BIIB & WFM Apr 24 2015
    Biogen's MS Drug Sales Light, Alzheimer's Data Pushed Back Apr 24 2015
    Techs surge on earnings, boosts Nasdaq, S&P 500 to record close Apr 24 2015
    Biogen Shares Not Too Healthy After Q1 Miss Apr 24 2015
    ​Biogen blames lower-than-expected Tecfidera sales partly on safety concerns Apr 24 2015
    Chips Fall, But Nasdaq Holds Up; Avago Slices 50-Day Line Apr 24 2015
    Biogen: Buy the Selloff Apr 24 2015
    Biogen Q1 Misses Estimates As Tecfidera Stalls Apr 24 2015
    US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft Apr 24 2015
    Trader blitz: AAL, DDD & more Apr 24 2015
    Here are five stocks making huge moves today Apr 24 2015
    Biogen says Tecfidera sales slow, delays data readout on Alzheimer's drug Apr 24 2015
    Jim Cramer Loves Regeneron, Sees Shares Headed to $500 Apr 24 2015
    US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft Apr 24 2015
    US STOCKS-Nasdaq hits 15-year high, propelled by Amazon, Microsoft Apr 24 2015
    Biogen: Significant Drop Follows 'Significant Slowing' Apr 24 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK